← Back to patent-cliff list
CAS 1304512-43-3
Methyl N-(tert-butoxycarbonyl)-L-tryptophyl-S-(acetamidomethyl)-L-cysteinate
Codes: (XIX)443746-2-d
Application context (from source-drug indications)
下丘脑肥胖Setmelanotide Acetate巴德特-别德尔综合征Setmelanotide AcetateObesitySetmelanotide AcetatePrader-Willi综合征Setmelanotide Acetate垂体疾病Setmelanotide Acetate联合性垂体激素缺乏症Setmelanotide Acetate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Setmelanotide Acetate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
Methyl L-tryptophyl-S-(acetamidomethyl)-L-cysteinate→Methyl N-(tert-butoxycarbonyl)-L-tryptophyl-S-(acetamidomethyl)-L-cysteinate→(2S)-3-(1H-Indol-3-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid→Methyl S-(acetamidomethyl)-L-cysteinate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.